Promis NeurosciencesPMN

13F holders, Q2 2025 (June 30)
19holders +3
6new positions
2sold out
1famous investor
$0.48avg. 13F price*

At the end of Q2 2025, 19 institutions reported holding Promis Neurosciences Inc. (PMN) in their 13F filings, up 3 from Q1 2025. 6 opened new positions and 2 sold out. The largest holders were Great Point Partners LLC ($1.3M), Armistice Capital, LLC ($1.0M) and Sphera Funds Management LTD. ($919K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Promis Neurosciences Inc.
CUSIP
74346M406
Latest filing quarter
Q3 2025

History

Number of 13F holders

0510152025 Q1 2024: 16Q1 2024Q2 2024: 16Q2 2024Q3 2024: 18Q3 2024Q4 2024: 17Q4 2024Q1 2025: 16Q1 2025Q2 2025: 19Q2 2025Q3 2025: 23Q3 2025

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions6$95K
Exits2$13K

All 13F filers, Q1 2025 → Q2 2025: 206,143 shares bought and 473,452 shares sold, net −267,309 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 19 holders

Great Point Partners LLC 0.83% No change 2,645,128 $1.3M
Armistice Capital, LLC 0.04% Reduce -8.4% 2,137,896 $1.0M
Sphera Funds Management LTD. 0.24% Reduce -1.6% 1,899,297 $919K
Ally Bridge Group (NY) LLC 0.54% Reduce -10.1% 1,334,428 $646K
Allostery Investments LP 0.97% Reduce -33.4% 155,720 $76K
Citadel Advisors 0.00% New 63,429 $31K
Graypoint LLC 0.00% New 52,833 $26K
Kingsview Wealth Management, LLC 0.00% New 31,062 $15K
Bank of Montreal 0.00% No change 30,366 $15K
Fiduciary Trust Co 0.00% Add +53.8% 28,583 $14K
Howard Financial Services, LTD. 0.00% New 26,042 $13K
Ieq Capital, LLC 0.00% No change 26,042 $13K
Commonwealth Equity Services, LLC 0.00% New 11,447 $6K
Scotia Capital Inc. 0.00% No change 12,122 $6K
Claret Asset Management Corp 0.00% New 11,330 $5K
Royal Bank of Canada 0.00% No change 5,487 $3K
Bank of America Corp. 0.00% No change 1,666 $805
TD Waterhouse Canada Inc. 0.00% No change 133 $64
National Bank of Canada 0.00% No change 88 $42

"% of holder's portfolio" is PMN's weight in each manager's 13F, not the share of Promis Neurosciences Inc. the manager owns.